Skip to main
PHR
PHR logo

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 58%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc is projected to achieve total revenue between $472.0 million and $482.0 million, reflecting a year-over-year growth of approximately 12% to 15%, surpassing prior consensus estimates. Notably, Network Solutions revenue is anticipated to grow by 25% year-over-year, outperforming market expectations, and contributing positively to overall financial performance. Additionally, the company's adjusted EBITDA guidance midpoint has increased by $2.0 million for FY26, indicating a strong bottom-line outlook that complements the healthy revenue projections.

Bears say

Phreesia Inc.'s financial outlook is negatively influenced by several key factors, including a projected slight decline in payment processing revenues due to seasonal effects, which signifies potential vulnerabilities in patient volume and spending patterns. The company's non-GAAP gross margin fell below expectations at 68.7%, reflecting challenges in maintaining profitability during a time of rising competitive pressures and economic uncertainties affecting healthcare spending. Additionally, the anticipated slowdown in organic growth and the broader economic downturn present substantial downside risks for future performance, potentially impacting the adoption of Phreesia's solutions across providers, payers, and life sciences.

Phreesia Inc (PHR) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 58% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 12 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.